Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 1,500 shares at $42.19 ($63K) on 2021-09-27, disclosed to the SEC on 2021-09-29.
Seasonal sale ($63k) by President and CEO — this insider has traded RGNX in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |